Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
US4800078A · kind A · utility
68Cited by
3References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 1987 |
| Grant date | Jan 24, 1989 |
| Priority date | — |
| Expiry date | May 28, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0073
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new immunotherapeutic method of treating lower respiratory tract infection caused by respiratory syncytial virus (RSV) is disclosed. The method employs topical application of RSV antibodies into the lower respiratory tract. The new treatment modality is more effective and rapid than the conventional therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.